Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review

S Nasreen, GB Gebretekle, M Lynch, A Kurdina… - Vaccine, 2022 - Elsevier
Background Pneumococcal disease causes substantial morbidity and mortality in older
adults. Pneumococcal polysaccharide vaccine (PPV23) is routinely recommended to reduce …

All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain

J Rejas, A Sicras-Mainar, A Sicras-Navarro… - Expert Review of …, 2022 - Taylor & Francis
Background Economic burden of community-acquired pneumonia (CAP) is recognized. Few
studies have documented such burden in adults stratified by age, risk status, and by care …

Long-term air pollution exposure and pneumonia-related mortality in a large pooled European cohort

S Liu, YH Lim, J Chen, M Strak, K Wolf… - American Journal of …, 2022 - atsjournals.org
Rationale: Ambient air pollution exposure has been linked to mortality from chronic
cardiorespiratory diseases, while evidence on respiratory infections remains more limited …

[HTML][HTML] Corynebacterium species inhibit Streptococcus pneumoniae colonization and infection of the mouse airway

KJ Horn, AC Jaberi Vivar, V Arenas, S Andani… - Frontiers in …, 2022 - frontiersin.org
The stability and composition of the airway microbiome is an important determinant of
respiratory health. Some airway bacteria are considered to be beneficial due to their …

The changing spectrum of microbial aetiology of respiratory tract infections in hospitalized patients before and during the COVID-19 pandemic

S Serigstad, DL Markussen, C Ritz, MH Ebbesen… - BMC Infectious …, 2022 - Springer
Background The COVID-19 pandemic was met with strict containment measures. We
hypothesized that societal infection control measures would impact the number of hospital …

Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial …

S Serigstad, C Ritz, D Faurholt-Jepsen, D Markussen… - Trials, 2022 - Springer
Background Community-acquired pneumonia (CAP) causes a large burden of disease. Due
to difficulties in obtaining representative respiratory samples and insensitive standard …

Cumulative occupational exposure to inorganic dust and fumes and invasive pneumococcal disease with pneumonia

K Torén, PD Blanc, R Naidoo, N Murgia… - International Archives of …, 2022 - Springer
Purpose Occupational exposure to inorganic dust and fumes in the year preceding disease
has been associated with increased pneumococcal pneumonia risk, but the impact of prior …

Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and …

C Hyams, E Begier, MG Gonzalez, J Southern… - BMJ open, 2022 - bmjopen.bmj.com
Objectives To determine the disease burden of acute lower respiratory tract disease
(aLRTD) and its subsets (pneumonia, lower respiratory tract infection (LRTI) and heart …

[HTML][HTML] Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 …

JJ LeBlanc, M ElSherif, L Ye, D MacKinnon-Cameron… - Vaccine, 2022 - Elsevier
Objective (s) In the context of age-and risk-based pneumococcal vaccine recommendations
in Canada, this study presents updated data from active surveillance of pneumococcal …

[HTML][HTML] Pneumococcal surface protein A-hybrid nanoparticles protect mice from lethal challenge after mucosal immunization targeting the lungs

DB Figueiredo, K Kaneko, TC Rodrigues… - Pharmaceutics, 2022 - mdpi.com
Pneumococcal disease remains a global burden, with current conjugated vaccines offering
protection against the common serotype strains. However, there are over 100 serotype …